Ex parte STARK et al. - Page 4




                 Appeal No. 1998-2280                                                                                                                   
                 Application No. 08/514,677                                                                                                             


                          Claims 1                                                                         through 7                                    
                 stand rejected                                                                            under 35                                     
                 U.S.C. § 103 as                                                                           unpatentable                                 
                 over Everaerts.            3                                                              (Examiner’s                                  
                 answer, pages 4-7.)                                                                                                                    
                          We reverse the aforementioned rejection for the reasons                                                                       
                 which follow.                                                                                                                          
                          Everaerts describes a radiation-crosslinkable composition                                                                     
                 comprising (a) an elastomeric polymer containing abstractable                                                                          
                 hydrogen atoms in an amount sufficient to enable the                                                                                   
                 elastomeric polymer to undergo crosslinking in the presence of                                                                         
                 a suitable radiation-activatable crosslinking agent; and (b) a                                                                         
                 radiation-activatable crosslinking agent of the formula:                                                                               











                          3The examiner has expressly withdrawn the rejection of                                                                        
                 claims 1-7 under 35 U.S.C. § 102(e) as anticipated by                                                                                  
                 Everaerts.  (Examiner’s answer, p. 3.)                                                                                                 
                                                                           4                                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007